Spots Global Cancer Trial Database for combination of pembrolizumab and platinum containing dual drugs
Every month we try and update this database with for combination of pembrolizumab and platinum containing dual drugs cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma | NCT06304350 | Esophageal Canc... | Combination of ... | 18 Years - 75 Years | Tongji University | |
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma | NCT06304350 | Esophageal Canc... | Combination of ... | 18 Years - 75 Years | Tongji University |